‘You can only flog a dead horse so many times’ – Dr David Wiseman on Covid-19 boosters

Loading player...
On 31 August, the FDA (United States Food and Drug Administration) announced that they had issued EUAs for BA4/5 bivalent Covid-19 quasi-vaccines. The EUA (emergency use authorisation) of these boosters signalled great cause for concern as it indicated that the FDA had once again undergone a further relaxing of their safety and efficacy standards. To discuss the FDA’s lowering standards and the apparent absence of pharmacovigilance, BizNews spoke to Dr David Wiseman, a PhD research bioscientist with a background in pharmacy, pharmacology, immunology and experimental pathology. Wiseman, with his extensive skill set and experience, having been one of the top 66 research scientists at Johnson & Johnson, provided clarity on confusing concepts and deep insight into the continued drive towards mass Covid-19 vaccination which he said has “become politicised”. The discussion around immunological addiction relating to the increasingly shortened periods between Covid-19 boosters was both fascinating and gravely concerning. – Nadya Swart Learn more about your ad choices. Visit megaphone.fm/adchoices
15 Sep 2022 8AM English South Africa Investing · Business News

Other recent episodes

The NdB Sunday Show | What Cyril knew before the Mkhwanazi presser…

In this edition of the NdB Sunday Show, Chris Steyn and independent intelligence analyst Jasmine Opperman talk about testimony at the Madlanga Commission of Inquiry that - six days before whistleblowing General Nhlanhla Mkhwanazi called his bombshell press conference - President Cyril Ramaphosa had a verbal intelligence briefing in which…
15 Nov 7AM 34 min

BN Edge | Piet le Roux: ICASA, Starlink and the true cost of BEE

To sell internet access in South Africa, you first have to show ICASA the race of your shareholders. Sakeliga has now taken the regulator to the Pretoria High Court, but, oddly, not to scrap the 30% black-ownership rule. Chief executive Piet le Roux told Alec Hogg why he chose the…
13 Nov 6AM 28 min